Cargando…
Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac Tissue Engineering with Human iPSC-derived Cardiomyocytes
[Image: see text] Natural polymer hydrogels are used ubiquitously as scaffold materials for cardiac tissue engineering as well as for soft tissue engineering more broadly because of FDA approval, minimal immunogenicity, and well-defined physiological clearance pathways. However, the relationships be...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372981/ https://www.ncbi.nlm.nih.gov/pubmed/30775432 http://dx.doi.org/10.1021/acsbiomaterials.8b01112 |
_version_ | 1783394874105528320 |
---|---|
author | Kaiser, Nicholas J. Kant, Rajeev J. Minor, Alicia J. Coulombe, Kareen L.K. |
author_facet | Kaiser, Nicholas J. Kant, Rajeev J. Minor, Alicia J. Coulombe, Kareen L.K. |
author_sort | Kaiser, Nicholas J. |
collection | PubMed |
description | [Image: see text] Natural polymer hydrogels are used ubiquitously as scaffold materials for cardiac tissue engineering as well as for soft tissue engineering more broadly because of FDA approval, minimal immunogenicity, and well-defined physiological clearance pathways. However, the relationships between natural polymer hydrogels and resident cell populations in directing the development of engineered tissues are poorly defined. This interaction is of particular concern for tissues prepared with iPSC-derived cell populations, in which population purity and batch-to-batch variability become additional critical factors to consider. Herein, the design space for a blended fibrin and collagen scaffold is characterized for applications in creating engineered myocardium with human iPSC-derived cardiomyocytes. Stiffness values of the acellular hydrogel formulations approach those of native myocardium in compression, but deviate significantly in tension when compared to rat myocardium in both transverse and longitudinal fiber orientations. A response surface methodology approach to understanding the relationship between collagen concentration, fibrin concentration, seeding density, and cardiac purity found a statistically significant predictive model across three repeated studies that confirms that all of these factors contribute to tissue compaction. In these constructs, increased fibrin concentration and seeding density were each associated with increased compaction, while increased collagen concentration was associated with decreased compaction. Both the lowest (24.4% cTnT(+)) and highest (60.2% cTnT(+)) cardiomyocyte purities evaluated were associated with decreased compaction, whereas the greatest compaction was predicted to occur in constructs prepared with a 40–50% cTnT(+) population. Constructs prepared with purified cardiomyocytes (≥75.5% cTnT(+)) compacted and formed syncytia well, although increased fibrin concentration in these groups was associated with decreased compaction, a reversal of the trend observed in unpurified cardiomyocytes. This study demonstrates an analytical approach to understanding cell–scaffold interactions in engineered tissues and provides a foundation for the development of more sophisticated and customized scaffold platforms for human cardiac tissue engineering. |
format | Online Article Text |
id | pubmed-6372981 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American
Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-63729812019-02-14 Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac Tissue Engineering with Human iPSC-derived Cardiomyocytes Kaiser, Nicholas J. Kant, Rajeev J. Minor, Alicia J. Coulombe, Kareen L.K. ACS Biomater Sci Eng [Image: see text] Natural polymer hydrogels are used ubiquitously as scaffold materials for cardiac tissue engineering as well as for soft tissue engineering more broadly because of FDA approval, minimal immunogenicity, and well-defined physiological clearance pathways. However, the relationships between natural polymer hydrogels and resident cell populations in directing the development of engineered tissues are poorly defined. This interaction is of particular concern for tissues prepared with iPSC-derived cell populations, in which population purity and batch-to-batch variability become additional critical factors to consider. Herein, the design space for a blended fibrin and collagen scaffold is characterized for applications in creating engineered myocardium with human iPSC-derived cardiomyocytes. Stiffness values of the acellular hydrogel formulations approach those of native myocardium in compression, but deviate significantly in tension when compared to rat myocardium in both transverse and longitudinal fiber orientations. A response surface methodology approach to understanding the relationship between collagen concentration, fibrin concentration, seeding density, and cardiac purity found a statistically significant predictive model across three repeated studies that confirms that all of these factors contribute to tissue compaction. In these constructs, increased fibrin concentration and seeding density were each associated with increased compaction, while increased collagen concentration was associated with decreased compaction. Both the lowest (24.4% cTnT(+)) and highest (60.2% cTnT(+)) cardiomyocyte purities evaluated were associated with decreased compaction, whereas the greatest compaction was predicted to occur in constructs prepared with a 40–50% cTnT(+) population. Constructs prepared with purified cardiomyocytes (≥75.5% cTnT(+)) compacted and formed syncytia well, although increased fibrin concentration in these groups was associated with decreased compaction, a reversal of the trend observed in unpurified cardiomyocytes. This study demonstrates an analytical approach to understanding cell–scaffold interactions in engineered tissues and provides a foundation for the development of more sophisticated and customized scaffold platforms for human cardiac tissue engineering. American Chemical Society 2018-12-10 2019-02-11 /pmc/articles/PMC6372981/ /pubmed/30775432 http://dx.doi.org/10.1021/acsbiomaterials.8b01112 Text en Copyright © 2018 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Kaiser, Nicholas J. Kant, Rajeev J. Minor, Alicia J. Coulombe, Kareen L.K. Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac Tissue Engineering with Human iPSC-derived Cardiomyocytes |
title | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac
Tissue Engineering with Human iPSC-derived Cardiomyocytes |
title_full | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac
Tissue Engineering with Human iPSC-derived Cardiomyocytes |
title_fullStr | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac
Tissue Engineering with Human iPSC-derived Cardiomyocytes |
title_full_unstemmed | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac
Tissue Engineering with Human iPSC-derived Cardiomyocytes |
title_short | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac
Tissue Engineering with Human iPSC-derived Cardiomyocytes |
title_sort | optimizing blended collagen-fibrin hydrogels for cardiac
tissue engineering with human ipsc-derived cardiomyocytes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372981/ https://www.ncbi.nlm.nih.gov/pubmed/30775432 http://dx.doi.org/10.1021/acsbiomaterials.8b01112 |
work_keys_str_mv | AT kaisernicholasj optimizingblendedcollagenfibrinhydrogelsforcardiactissueengineeringwithhumanipscderivedcardiomyocytes AT kantrajeevj optimizingblendedcollagenfibrinhydrogelsforcardiactissueengineeringwithhumanipscderivedcardiomyocytes AT minoraliciaj optimizingblendedcollagenfibrinhydrogelsforcardiactissueengineeringwithhumanipscderivedcardiomyocytes AT coulombekareenlk optimizingblendedcollagenfibrinhydrogelsforcardiactissueengineeringwithhumanipscderivedcardiomyocytes |